1. Home
  2. HURA vs RRGB Comparison

HURA vs RRGB Comparison

Compare HURA & RRGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • RRGB
  • Stock Information
  • Founded
  • HURA 2009
  • RRGB 1969
  • Country
  • HURA United States
  • RRGB United States
  • Employees
  • HURA N/A
  • RRGB N/A
  • Industry
  • HURA
  • RRGB Restaurants
  • Sector
  • HURA
  • RRGB Consumer Discretionary
  • Exchange
  • HURA Nasdaq
  • RRGB Nasdaq
  • Market Cap
  • HURA 103.3M
  • RRGB 88.7M
  • IPO Year
  • HURA N/A
  • RRGB 2002
  • Fundamental
  • Price
  • HURA $2.33
  • RRGB $5.65
  • Analyst Decision
  • HURA Strong Buy
  • RRGB Strong Buy
  • Analyst Count
  • HURA 2
  • RRGB 4
  • Target Price
  • HURA $11.50
  • RRGB $11.88
  • AVG Volume (30 Days)
  • HURA 475.4K
  • RRGB 350.7K
  • Earning Date
  • HURA 08-15-2025
  • RRGB 08-21-2025
  • Dividend Yield
  • HURA N/A
  • RRGB N/A
  • EPS Growth
  • HURA N/A
  • RRGB N/A
  • EPS
  • HURA N/A
  • RRGB N/A
  • Revenue
  • HURA N/A
  • RRGB $1,252,370,000.00
  • Revenue This Year
  • HURA N/A
  • RRGB N/A
  • Revenue Next Year
  • HURA $69.15
  • RRGB N/A
  • P/E Ratio
  • HURA N/A
  • RRGB N/A
  • Revenue Growth
  • HURA N/A
  • RRGB N/A
  • 52 Week Low
  • HURA $1.80
  • RRGB $2.50
  • 52 Week High
  • HURA $10.49
  • RRGB $7.05
  • Technical
  • Relative Strength Index (RSI)
  • HURA N/A
  • RRGB 56.69
  • Support Level
  • HURA N/A
  • RRGB $5.88
  • Resistance Level
  • HURA N/A
  • RRGB $6.89
  • Average True Range (ATR)
  • HURA 0.00
  • RRGB 0.42
  • MACD
  • HURA 0.00
  • RRGB -0.05
  • Stochastic Oscillator
  • HURA 0.00
  • RRGB 61.14

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About RRGB Red Robin Gourmet Burgers Inc.

Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.

Share on Social Networks: